Different training-induced skeletal muscle adaptations in COPD patients with and without alpha-1 antitrypsin deficiency

Respiration

Volumn 92, Issue 5, 2016, Pages 339-347

  Jarosch, Inga ^a   Gehlert, Sebastian ^a   Jacko, Daniel ^a   Koczulla, Rembert Andreas ^a   Wencker, Marion ^a   Welte, Tobias ^a   Bloch, Wilhelm ^a   Janciauskiene, Sabina ^a   Kenn, Klaus ^a  

^a Dept of Respiratory Medicine and Exercise Therapy   (Germany)

Author keywords

Alpha 1 antitrypsin deficiency; Chronic obstructive pulmonary disease; Exercise training; Pulmonary rehabilitation; Skeletal muscle

Indexed keywords

ALPHA 1 ANTITRYPSIN CONCENTRATE; MITOCHONDRIAL PROTEIN; DNA BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PPARGC1A PROTEIN, HUMAN; TFAM PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADAPTATION; ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BODY PLETHYSMOGRAPH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYCLING; FEMALE; HUMAN; MALE; MIDDLE AGED; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE TRAINING; OXIDATIVE STRESS; PRIORITY JOURNAL; PULMONARY REHABILITATION; SENSOR; SKELETAL MUSCLE; VASTUS LATERALIS MUSCLE; AGED; ALPHA 1-ANTITRYPSIN DEFICIENCY; CASE CONTROL STUDY; COMPLICATION; EXERCISE TEST; FAST MUSCLE FIBER; LUNG DIFFUSION CAPACITY; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS FEMORIS MUSCLE; RESPIRATORY CARE; SLOW MUSCLE FIBER; STATISTICAL MODEL; WESTERN BLOTTING;

ADAPTATION, PHYSIOLOGICAL; AGED; ALPHA 1-ANTITRYPSIN DEFICIENCY; BLOTTING, WESTERN; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; EXERCISE TEST; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE, SKELETAL; OXIDATION-REDUCTION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-ALPHA; PROSPECTIVE STUDIES; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; RESPIRATORY THERAPY; TRANSCRIPTION FACTORS;

EID: 84990220369     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000449509     Document Type: Article

References (33)

1. Gosker HR, Zeegers MP, Wouters EF, Schols AM. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-Analysis. Thorax 2007; 62: 944-949
2. Whittom F, Jobin J, Simard PM, Leblanc P, Simard C, Bernard S, et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998; 30: 1467-1474
3. Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigare R, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014; 189: e15-e62
4. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188: e13-e64
5. Osadnik CR, Rodrigues FM, Camillo CA, Loeckx M, Janssens W, Dooms C, et al. Principles of rehabilitation and reactivation. Respiration 2015; 89: 2-11
6. Man WD, Kemp P, Moxham J, Polkey MI. Exercise and muscle dysfunction in COPD: implications for pulmonary rehabilitation. Clin Sci (Lond) 2009; 117: 281-291
7. Vogiatzis I, Terzis G, Nanas S, Stratakos G, Simoes DC, Georgiadou O, et al. Skeletal muscle adaptations to interval training in patients with advanced COPD. Chest 2005; 128: 3838-3845
8. Wittmann M, Stojanovic K, Schultz K. Effectiveness of a 3-week in-patient rehabilitation program in patients with COPD GOLD stage IV. Eur Respir J 2013; 42(suppl 54): A2221
9. Greulich T, Koczulla AR, Nell C, Kehr K, Vogelmeier CF, Stojanovic D, et al. Effect of a three-week inpatient rehabilitation program on 544 consecutive patients with very severe COPD: a retrospective analysis. Respiration 2015; 90: 287-292
10. Seersholm N, Kok-Jensen A. Clinical features and prognosis of life time non-smokers with severe alpha 1-Antitrypsin deficiency. Thorax 1998; 53: 265-268
11. Marciniuk DD, Hernandez P, Balter M, Bourbeau J, Chapman KR, Ford GT, et al. Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline. Can Respir J 2012; 19: 109-116
12. Kenn K, Gloeckl R, Soennichsen A, Sczepanski B, Winterkamp S, Boensch M, et al. Predictors of success for pulmonary rehabilitation in patients awaiting lung transplantation. Transplantation 2015; 99: 1072-1077
13. Gloeckl R, Heinzelmann I, Baeuerle S, Damm E, Schwedhelm AL, Diril M, et al. Effects of whole body vibration in patients with chronic obstructive pulmonary disease-A randomized controlled trial. Respir Med 2012; 106: 75-83
14. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555
15. ATS Statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117
16. Gehlert S, Suhr F, Gutsche K, Willkomm L, Kern J, Jacko D, et al. High force development augments skeletal muscle signalling in resistance exercise modes equalized for time under tension. Pflugers Arch 2015; 467: 1343-1356
17. Mitchell CJ, Churchward-Venne TA, Bellamy L, Parise G, Baker SK, Phillips SM. Muscular and systemic correlates of resistance traininginduced muscle hypertrophy. PLoS One 2013; 8: e78636
18. Akimoto T, Pohnert SC, Li P, Zhang M, Gumbs C, Rosenberg PB, et al. Exercise stimulates PGC-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway. J Biol Chem 2005; 280: 19587-19593
19. Bronstad E, Rognmo O, Tjonna AE, Dedichen HH, Kirkeby-Garstad I, Haberg AK, et al. High-intensity knee extensor training restores skeletal muscle function in COPD patients. Eur Respir J 2012; 40: 1130-1136
20. Puente-Maestu L, Lazaro A, Tejedor A, Camano S, Fuentes M, Cuervo M, et al. Effects of exercise on mitochondrial DNA content in skeletal muscle of patients with COPD. Thorax 2011; 66: 121-127
21. Maltais F, LeBlanc P, Simard C, Jobin J, Berube C, Bruneau J, et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154(2 Pt 1): 442-447
22. Clini E, Foglio K, Bianchi L, Porta R, Vitac-ca M, Ambrosino N. In-hospital short-Term training program for patients with chronic airway obstruction. Chest 2001; 120: 1500-1505
23. Singh SJ, Puhan MA, Andrianopoulos V, Hernandes NA, Mitchell KE, Hill CJ, et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J 2014; 44: 1447-1478
24. Puhan MA, Chandra D, Mosenifar Z, Ries A, Make B, Hansel NN, et al. The minimal important difference of exercise tests in severe COPD. Eur Respir J 2011; 37: 784-790
25. Vogiatzis I, Simoes DC, Stratakos G, Kourepini E, Terzis G, Manta P, et al. Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD. Eur Respir J 2010; 36: 301-310
26. Williamson DL, Gallagher PM, Carroll CC, Raue U, Trappe SW. Reduction in hybrid single muscle fiber proportions with resistance training in humans. J Appl Physiol 2001; 91: 1955-1961
27. Gouzi F, Prefaut C, Abdellaoui A, Roudier E, de Rigal P, Molinari N, et al. Blunted muscle angiogenic training-response in COPD patients versus sedentary controls. Eur Respir J 2013; 41: 806-814
28. Gouspillou G, Sgarioto N, Norris B, Barbat-Artigas S, Aubertin-Leheudre M, Morais JA, et al. The relationship between muscle fiber type-specific PGC-1alpha content and mitochondrial content varies between rodent models and humans. PLoS One 2014; 9: e103044
29. Frenzel E, Wrenger S, Brugger B, Salipalli S, Immenschuh S, Aggarwal N, et al. Alpha1-Antitrypsin combines with plasma fatty acids and induces angiopoietin-like protein 4 expression. J Immunol 2015; 195: 3605-3616
30. Jonker JT, Smit JW, Hammer S, Snel M, van der Meer RW, Lamb HJ, et al. Dietary modulation of plasma angiopoietin-like protein 4 concentrations in healthy volunteers and in patients with type 2 diabetes. Am J Clin Nutr 2013; 97: 255-260
31. Catoire M, Alex S, Paraskevopulos N, Mattijssen F, Evers-van Gogh I, Schaart G, et al. Fatty acid-inducible ANGPTL4 governs lipid metabolic response to exercise. Proc Natl Acad Sci USA 2014; 111: E1043-E1052
32. Hamilton MT, Hamilton DG, Zderic TW. Exercise physiology versus inactivity physiology: an essential concept for understanding lipoprotein lipase regulation. Exerc Sport Sci Rev 2004; 32: 161-166
33. Andersen P, Henriksson J. Capillary supply of the quadriceps femoris muscle of man: adaptive response to exercise. J Physiol 1977; 270: 677-690